165 related articles for article (PubMed ID: 16965672)
1. [Nanoliposomal quercetin inhibits formation of malignant ascites of hepatocellular carcinoma].
Yuan ZP; Chen LJ; Wei YQ; Fan LY; Tang MH; Yang GL
Ai Zheng; 2006 Aug; 25(8):941-5. PubMed ID: 16965672
[TBL] [Abstract][Full Text] [Related]
2. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
[TBL] [Abstract][Full Text] [Related]
3. The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC.
Zhang Q; Ju YH; Zhang Y; Wang K; Zhang M; Chen PD; Yao WF; Tang YP; Wu JH; Zhang L
J Ethnopharmacol; 2021 Mar; 267():113507. PubMed ID: 33098970
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
5. [Studies on antitumor effects of podophyllotoxin nanoliposome].
Zhang XY; Ni JM; Qiao H
Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(2):148-50. PubMed ID: 16570806
[TBL] [Abstract][Full Text] [Related]
6. Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma.
Varshosaz J; Jafarian A; Salehi G; Zolfaghari B
J Liposome Res; 2014 Sep; 24(3):191-203. PubMed ID: 24354715
[TBL] [Abstract][Full Text] [Related]
7. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y
Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharides Extracted from
Fang Y; Ning A; Li S; Zhou S; Liu L; Joseph TP; Zhong M; Jiao J; Zhang W; Shi Y; Zhang M; Huang M
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735884
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
10. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848
[TBL] [Abstract][Full Text] [Related]
11. Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma.
Tagaram HR; Divittore NA; Barth BM; Kaiser JM; Avella D; Kimchi ET; Jiang Y; Isom HC; Kester M; Staveley-O'Carroll KF
Gut; 2011 May; 60(5):695-701. PubMed ID: 21193455
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
13. [Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression].
Cai YJ; Zheng DY; Luo RC; Chen JZ; Li AM; Xi JL; Ding XM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):647-9. PubMed ID: 17545079
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
15. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.
Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Li L; Lin YY
Eur J Cancer; 2012 Sep; 48(14):2260-9. PubMed ID: 22257793
[TBL] [Abstract][Full Text] [Related]
16. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ
Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells.
Xi S; Hong R; Huang J; Lu D; Qian L; Li P; Wen L; Wang Y
Afr J Tradit Complement Altern Med; 2014; 11(4):94-100. PubMed ID: 25392588
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells.
Chang YF; Chi CW; Wang JJ
Nutr Cancer; 2006; 55(2):201-9. PubMed ID: 17044776
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.
Xiao S; Wang Y; Ma W; Zhou P; Wang B; Wu Z; Wen Q; Xiong K; Liu Y; Fu S
Drug Deliv; 2022 Dec; 29(1):2713-2722. PubMed ID: 35975331
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
Lin YY; Li JJ; Chang CH; Lu YC; Hwang JJ; Tseng YL; Lin WJ; Ting G; Wang HE
Cancer Biother Radiopharm; 2009 Aug; 24(4):453-60. PubMed ID: 19694580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
